Vaso Corporation Share Price

Equities

VASO

US92233F1021

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 01:29:04 27/04/2024 am IST 5-day change 1st Jan Change
0.284 USD +1.46% Intraday chart for Vaso Corporation -3.66% -6.89%
Sales 2022 80.02M 6.67B Sales 2023 81.02M 6.76B Capitalization 53.47M 4.46B
Net income 2022 11M 917M Net income 2023 4M 334M EV / Sales 2022 0.13 x
Net cash position 2022 18.52M 1.54B Net cash position 2023 23.26M 1.94B EV / Sales 2023 0.37 x
P/E ratio 2022
2.41 x
P/E ratio 2023
11.1 x
Employees 300
Yield 2022 *
-
Yield 2023
-
Free-Float 52.4%
More Fundamentals * Assessed data
Dynamic Chart
Vaso Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Vaso Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Vaso Corporation entered into a business combination agreement to acquire Achari Ventures Holdings Corp. I from Achari Sponsor Holdings I LLC and others for approximately $190 million in a reverse merger transaction. CI
Vaso Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Vaso Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Vaso Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Vaso Corporation Appoints Leon Dembo as Independent Director CI
Vaso Corporation Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Vaso Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Vaso Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Vaso Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Vaso Corporation Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Vaso Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Vaso Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Vaso Corporation Receives Confirmation That the Small Business Administration Approves the Company's PPP Note Forgiveness Application CI
More news
1 day+1.46%
1 week-3.66%
Current month-5.36%
1 month-6.89%
3 months-0.60%
6 months-5.33%
Current year-6.89%
More quotes
1 week
0.26
Extreme 0.2573
0.29
1 month
0.25
Extreme 0.2511
0.32
Current year
0.23
Extreme 0.231
0.34
1 year
0.19
Extreme 0.191
0.37
3 years
0.04
Extreme 0.04
0.37
5 years
0.01
Extreme 0.0104
0.37
10 years
0.01
Extreme 0.0104
0.37
More quotes
Managers TitleAgeSince
Chief Executive Officer 60 01/07/01
Director of Finance/CFO 63 01/10/01
Director of Finance/CFO 79 21/11/21
Members of the board TitleAgeSince
Chief Operating Officer 55 19/10/19
Chief Executive Officer 60 01/07/01
Director/Board Member 79 28/11/28
More insiders
Date Price Change Volume
26/24/26 0.284 +1.46% 24,261
25/24/25 0.2799 +3.67% 27,841
24/24/24 0.27 -7.50% 37,191
23/24/23 0.2919 +6.07% 23,311
22/24/22 0.2752 -6.65% 24,640

Delayed Quote OTC Markets, April 27, 2024 at 01:29 am IST

More quotes
Vaso Corporation is principally engaged in operating the healthcare equipment and information technology industries. The Company's segments include IT, Professional sales service, and Equipment. The IT segment operates through a wholly owned subsidiary, VasoTechnology, Inc., which primarily focuses on healthcare information technology (IT) and managed network technology services. Its Professional sales service segment operates through a wholly owned subsidiary, Vaso Diagnostics, Inc. doing business as VasoHealthcare, primarily focuses on the sale of healthcare capital equipment for GE HealthCare (GEHC) into the health provider middle market. Its Equipment segment primarily focuses on the design, manufacture, sale and service of proprietary medical devices and software, operating through the Company's subsidiary, VasoMedical, Inc., which in turn operates through Vasomedical Solutions, Inc. for domestic business and Vasomedical Global Corp. for international business, respectively.
More about the company